How Arsenic Affects Insulin Signaling and Diabetes
Author Information
Author(s): Paul David S., Harmon Anne W., Devesa Vicenta, Thomas David J., Stýblo Miroslav
Primary Institution: The University of North Carolina at Chapel Hill
Hypothesis
What are the molecular mechanisms by which arsenic inhibits insulin signaling and contributes to diabetes?
Conclusion
Arsenic inhibits insulin-stimulated glucose uptake in adipocytes by disrupting the signaling pathway that activates protein kinase B/Akt.
Supporting Evidence
- Arsenite and methylarsonous acid were shown to inhibit insulin-stimulated glucose uptake in adipocytes.
- Both arsenicals suppressed the phosphorylation of protein kinase B/Akt, which is crucial for glucose uptake.
- Constitutively active PKB/Akt restored normal glucose uptake in the presence of arsenicals.
Takeaway
Arsenic can make it harder for our bodies to use sugar by blocking the signals that help cells take in glucose, which can lead to diabetes.
Methodology
The study examined the effects of arsenite and methylarsonous acid on insulin signaling in 3T3-L1 adipocytes, focusing on the phosphorylation of key proteins involved in glucose uptake.
Limitations
The study primarily used in vitro models, which may not fully replicate the complexities of human physiology.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website